
  
    
      
        Introduction_NNP
        Transforming_NNP growth_NN factor_NN (_( TGF_NNP )_) -_: β_NN is_VBZ a_DT dimeric_JJ protein_NN
        of_IN 25_CD kDa_NN molecular_JJ weight_NN ,_, originally_RB isolated_VBN from_IN
        platelets_NNS [_NN 1_CD 2_CD ]_NN ._. There_EX are_VBP three_CD distinct_JJ mammalian_JJ
        isoforms_NNS ,_, TGF-β_NNP 1_CD ,_, TGF-β_NNP 2_CD and_CC TGF-β_NNP 3_CD ,_, with_IN TGF-β_NNP 1_CD being_VBG the_DT
        most_RBS abundant_JJ isoform_NN ._. Almost_RB all_DT cell_NN types_NNS express_VBP TGF-β_NNP ,_,
        but_CC the_DT highest_JJS level_NN of_IN expression_NN of_IN TGF-β_NNP is_VBZ in_IN
        platelets_NNS and_CC bone_NN [_NN 3_CD ]_NN ._. Mature_NNP TGF-β_NNP 1_CD consists_VBZ of_IN two_CD
        identical_JJ peptide_NN chains_NNS ,_, each_DT containing_VBG 112_CD amino_JJ acids_NNS ,_,
        linked_VBN via_IN nine_CD disulfide_NN bonds_NNS [_NN 4_CD ]_NN ._. TGF-β_NNP 1_CD is_VBZ
        synthesized_JJ as_IN part_NN of_IN a_DT large_JJ ,_, latent_NN protein_NN complex_JJ ,_,
        unable_JJ to_TO bind_NN to_TO cellular_JJ receptors_NNS ,_, with_IN mature_VBP active_JJ
        TGF-β_NNP 1_CD produced_VBN by_IN cleavage_NN [_NN 5_CD ]_NN ._.
        TGF-β_NNP 1_CD is_VBZ a_DT mutifunctional_NN cytokine_NN that_WDT plays_VBZ an_DT
        important_JJ role_NN in_IN immunomodulation_NN ,_, inflammation_NN and_CC tissue_NN
        repair_NN [_NN 6_CD ]_NN ._. Many_JJ studies_NNS have_VBP suggested_VBN that_IN TGF-β_NNP could_MD
        be_VB a_DT potential_JJ therapeutic_JJ reagent_NN for_IN the_DT repair_NN of_IN soft_JJ
        tissue_NN and_CC bone_NN ,_, and_CC following_VBG ischemic_JJ injury_NN ._. It_PRP may_MD also_RB
        have_VB applications_NNS for_IN the_DT treatment_NN of_IN chronic_JJ inflammatory_JJ
        fibrotic_JJ and_CC autoimmune_JJ diseases_NNS [_NN 7_CD 8_CD ]_NN ._. In_IN contrast_NN ,_,
        other_JJ studies_NNS have_VBP demonstrated_VBN that_IN TGF-β_NNP 1_CD can_MD cause_VB
        inflammation_NN and_CC fibrosis_NNS [_NN 9_CD 10_CD ]_NN ._. The_DT potential_JJ use_NN of_IN
        TGF-β_NNP 1_CD for_IN the_DT treatment_NN of_IN human_JJ disease_NN thus_RB remains_VBZ
        controversial_JJ [_NN 11_CD ]_NN ._.
        Rheumatoid_NNP arthritis_NN is_VBZ a_DT systemic_JJ ,_, autoimmune_JJ disease_NN ._.
        It_PRP is_VBZ characterized_VBN by_IN a_DT chronic_JJ ,_, erosive_JJ inflammation_NN of_IN
        painful_JJ and_CC debilitating_JJ joints_NNS ,_, with_IN progressive_JJ
        degradation_NN of_IN cartilage_NN and_CC bone_NN accompanied_VBN by_IN
        proliferation_NN of_IN the_DT synovium_NN [_NN 12_CD ]_NN ._. Rheumatoid_NNP arthritis_NN
        remains_VBZ incurable_JJ and_CC ,_, in_IN many_JJ patients_NNS ,_, difficult_JJ to_TO
        treat_VB ._. As_IN a_DT novel_NN approach_NN to_TO therapy_NN ,_, we_PRP and_CC other_JJ workers_NNS
        have_VBP focused_VBN on_IN developing_VBG the_DT methods_NNS for_IN local_JJ transfer_NN
        of_IN genes_NNS encoding_VBG therapeutic_JJ agents_NNS to_TO the_DT joint_JJ [_NN 13_CD 14_CD
        15_CD 16_CD 17_CD 18_CD 19_CD ]_NN ._. This_DT strategy_NN also_RB can_MD be_VB applied_VBN to_TO the_DT
        treatment_NN of_IN osteoarthritis_NNS and_CC for_IN aiding_VBG the_DT repair_NN of_IN
        the_DT cartilage_NN and_CC other_JJ intra-articular_JJ tissues_NNS ._.
        Since_IN TGF-β_NNP 1_CD has_VBZ anti-inflammatory_JJ properties_NNS as_RB well_RB as_IN
        being_VBG able_JJ to_TO stimulate_VB new_JJ matrix_NN synthesis_NN by_IN
        chondrocytes_NNS ,_, it_PRP represents_VBZ a_DT possible_JJ therapeutic_JJ agent_NN
        with_IN which_WDT to_TO treat_VB pathologies_NNS associated_VBN with_IN rheumatoid_NN
        arthritis_NN and_CC osteoarthritis_NNS by_IN local_JJ gene_NN delivery_NN ._. Other_JJ
        workers_NNS and_CC ourselves_PRP have_VBP previously_RB examined_VBN the_DT effects_NNS
        of_IN TGF-β_NNP 1_CD gene_NN transfer_NN on_IN matrix_NN synthesis_NN in_IN chondrocyte_NN
        cultures_NNS ,_, demonstrating_VBG a_DT significant_JJ stimulation_NN in_IN the_DT
        production_NN of_IN proteoglycans_NNS [_NN 9_CD ]_NN ._. In_IN addition_NN ,_, we_PRP have_VBP
        demonstrated_VBN that_IN the_DT TGF-β_NNP 1_CD gene_NN was_VBD able_JJ to_TO overcome_VB the_DT
        inhibitory_NN effects_NNS of_IN IL-_NNP 1_CD β_NN on_IN matrix_NN metabolism_NN in_IN
        chondrocytes_NNS in_IN culture_NN [_NN 20_CD ]_NN ._.
        To_TO examine_VB the_DT effect_NN of_IN TGF-β_NNP 1_CD on_IN joint_JJ pathology_NN ,_, we_PRP
        used_VBD adenovirus-mediated_JJ intra-articular_JJ gene_NN delivery_NN to_TO
        confer_VB sustained_VBN ,_, intra-articular_JJ TGF-β_NNP 1_CD expression_NN in_IN both_DT
        naïve_NN and_CC arthritic_JJ rabbit_NN knee_NN joints_NNS ._. Intra-articular_NNP
        injection_NN of_IN adenoviral_NN vector_NN expressing_VBG human_JJ
        transforming_VBG growth_NN factor_NN (_( Ad_NN ._. TGF_NNP )_) -_: β_NN 1_CD resulted_VBD in_IN a_DT high_JJ
        level_NN of_IN TGF-β_NNP 1_CD accumulation_NN in_IN the_DT synovial_NN fluid_JJ ._.
        Intra-articular_NNP TGF-β_NNP 1_CD expression_NN was_VBD anti-inflammatory_JJ ,_,
        inhibiting_VBG white_JJ blood_NN cells_NNS ._. However_RB ,_, TGF-β_NNP 1_CD expression_NN
        also_RB induced_VBD significant_JJ pathology_NN in_IN the_DT rabbit_NN knee_NN as_RB
        well_RB as_IN in_IN the_DT adjacent_JJ muscle_NN ,_, including_VBG stimulation_NN of_IN
        glycosaminoglycan_NN (_( GAG_NNP )_) release_NN and_CC nitric_JJ oxide_NN synthesis_NN ,_,
        and_CC enhancement_NN of_IN fibrogenesis_NNS and_CC muscle_NN edema_NN ._. These_DT
        results_NNS suggest_VBP that_IN ,_, although_IN TGF-β_NNP 1_CD may_MD have_VB
        anti-inflammatory_JJ effects_NNS ,_, sustained_VBN expression_NN of_IN TGF-β_NNP 1_CD
        has_VBZ adverse_JJ effects_NNS on_IN joint_JJ pathology_NN ._.
      
      
        Materials_NNS and_CC methods_NNS
        
          Vector_NNP construction_NN
          The_DT recombinant_JJ adenoviral_NN vector_NN used_VBN in_IN the_DT present_JJ
          study_NN originates_VBZ from_IN replication-deficient_JJ type_NN 5_CD
          adenovirus_JJ lacking_VBG E_NNP 1_CD and_CC E_NNP 3_CD loci_NN [_NN 21_CD ]_NN ._. The_DT human_JJ
          TGF-β_NNP 1_CD cDNA_NN was_VBD inserted_VBN in_IN place_NN of_IN the_DT E_NNP 1_CD region_NN in_IN the_DT
          shuttle_NN plasmid_NN pAd-Lox_JJ [_NN 22_CD ]_NN ,_, where_WRB expression_NN is_VBZ
          driven_VBN by_IN the_DT cytomegalovirus_JJ promoter_NN ._.
          The_DT recombinant_JJ Ad_NN ._. TGF-β_NNP 1_CD virus_NN was_VBD generated_VBN by_IN
          Cre-_NNP Lox-driven_NNP recombination_NN in_IN Cre_NNP 8_CD cells_NNS [_NN 22_CD ]_NN ._.
          Briefly_NNP ,_, a_DT confluent_NN 10_CD cm_NN 2_CD dish_NN of_IN Cre_NNP 8_CD cells_NNS (_( 1_CD ._. 6_CD ×_NN 10_CD
          7_CD )_) was_VBD split_VBN into_IN five_CD 6_CD cm_NN 2_CD dishes_NNS ._. Transfection_NNP of_IN
          these_DT cells_NNS with_IN pAd-Lox-human_JJ TGF-β_NNP 1_CD was_VBD performed_VBN by_IN
          the_DT calcium_NN phosphate_NN precipitation_NN method_NN with_IN 3_CD μg_NN
          pAd-Lox-human_JJ TGF-β_NNP 1_CD construct_VB digested_VBN with_IN 
          Sfi_NNP I_PRP and_CC 3_CD μg_NN ψ_NN 5_CD helper_NN virus_NN DNA_NNP ._.
          The_DT transfected_JJ Cre_NNP 8_CD cells_NNS were_VBD fed_VBN daily_JJ until_IN there_EX
          were_VBD visible_JJ plaques_NNS ._. The_DT cells_NNS were_VBD harvested_VBN and_CC
          exposed_VBN to_TO three_CD cycles_NNS of_IN freeze_NN /_NN thaw_NN ._. The_DT recombinant_JJ
          virus_NN was_VBD purified_JJ and_CC amplified_VBN by_IN infecting_VBG two_CD 10_CD cm_NN
          dishes_NNS of_IN Cre_NNP 8_CD cells_NNS using_VBG 100_CD μl_NN lysate_NN ._. The_DT Ad_NN ._. TGF-β_NNP 1_CD
          virus_NN was_VBD purified_JJ using_VBG cesium_NN chloride_NN gradient_NN
          ultracentrifugation_NN at_IN 154_CD ,_, 000_CD 
          g_SYM (_( 30_CD ,_, 000_CD rpm_NN )_) and_CC 4_CD °_NN C_NNP ,_, and_CC then_RB
          dialyzed_JJ three_CD times_NNS against_IN Tris-buffered_NNP saline_NN ._.
          The_DT titer_NN was_VBD determined_VBN by_IN measuring_VBG the_DT viral_JJ DNA_NNP at_IN
          optical_JJ density_NN 260_CD nm_NN (_( OD_NNP 
          260_CD nm_NN )_) using_VBG the_DT formula_NN :_: viral_JJ
          particles_NNS =_SYM OD_NNP 
          260_CD nm_NN ×_NN dilution_NN /_NN 9_CD ._. 09_CD ×_NN 10_CD -_: 13_CD ._. The_DT
          adenovirus_JJ expressing_VBG luciferase_NN was_VBD kindly_RB provided_VBN by_IN J_NNP
          Kolls_NNP (_( LSU_NNP Medical_NNP Center_NNP ,_, New_NNP Orleans_NNP ,_, LA_NNP ,_, USA_NNP )_) ._.
        
        
          Animals_NNS and_CC experimental_JJ arthritis_NN
          New_NNP Zealand_NNP white_JJ rabbits_NNS ,_, weighing_VBG 4_CD -_: 5_CD kg_NN ,_, were_VBD
          purchased_VBN from_IN Myrtles_NNP Rabbitry_NNP (_( Thompson_NNP Station_NNP ,_, TN_NNP ,_,
          USA_NNP )_) ._. To_TO establish_VB antigen-induced_JJ arthritis_NN (_( AIA_NNP )_) ,_,
          rabbits_NNS were_VBD sensitized_JJ to_TO ovalbumin_NN by_IN intradermal_NN
          injections_NNS of_IN 5_CD mg_NN ovalbumin_NN emulsified_JJ in_IN Freund_NNP 's_POS
          complete_JJ adjuvant_NN ._. Arthritis_NNP was_VBD initiated_VBN in_IN both_DT hind_NN
          knees_NNS of_IN rabbits_NNS 3_CD weeks_NNS later_RB by_IN the_DT intra-articular_JJ
          injection_NN of_IN 5_CD mg_NN ovalbumin_NN dissolved_VBN in_IN 0_CD ._. 5_CD ml_NN Gey_NNP 's_POS
          saline_NN ._. The_DT different_JJ adenoviral_NN vectors_NNS were_VBD injected_VBN
          intra-articularly_JJ 24_CD hours_NNS after_IN injection_NN of_IN
          antigen_NN ._.
        
        
          Experimental_NNP protocol_NN
          Twenty-four_CD hours_NNS after_IN induction_NN of_IN AIA_NNP ,_, adenoviral_NN
          particles_NNS encoding_VBG either_CC the_DT human_JJ TGF-β_NNP 1_CD or_CC luciferase_NN
          were_VBD suspended_VBN in_IN 0_CD ._. 2_CD ml_NN Gey_NNP 's_POS saline_NN and_CC injected_VBN into_IN
          the_DT joint_JJ space_NN of_IN the_DT knee_NN through_IN the_DT patellar_NN tendon_NN ._.
          Different_JJ doses_NNS of_IN virus_NN (_( 1_CD ×_NN 10_CD 7_CD ,_, 1_CD ×_NN 10_CD 8_CD and_CC 1_CD ×_NN 10_CD 9_CD )_)
          viral_JJ particles_NNS were_VBD injected_VBN intra-articularly_JJ into_IN
          three_CD rabbits_NNS per_IN group_NN for_IN analysis_NN of_IN the_DT effects_NNS of_IN
          TGF-β_NNP 1_CD on_IN naïve_NN joint_JJ pathology_NN ,_, and_CC the_DT treated_VBN rabbits_NNS
          were_VBD sacrificed_JJ 7_CD days_NNS postinfection_NN to_TO observe_VB the_DT
          dose-response_JJ effects_NNS ._. Another_DT group_NN of_IN three_CD naïve_NN
          rabbits_NNS was_VBD injected_VBN with_IN 1_CD ×_NN 10_CD 9_CD viral_JJ particles_NNS and_CC
          sacrificed_JJ 17_CD days_NNS postinfection_NN for_IN long-term_JJ
          observation_NN ._.
          There_EX were_VBD two_CD groups_NNS of_IN AIA_NNP rabbits_NNS used_VBN in_IN the_DT
          study_NN ._. The_DT first_JJ group_NN of_IN three_CD rabbits_NNS was_VBD injected_VBN with_IN
          1_CD ×_NN 10_CD 8_CD viral_JJ particles_NNS ,_, and_CC the_DT second_JJ group_NN of_IN six_CD
          rabbits_NNS was_VBD injected_VBN with_IN 1_CD ×_NN 10_CD 9_CD viral_JJ particles_NNS ._. Each_DT
          rabbit_NN received_VBD the_DT indicated_VBN dose_NN of_IN TGF-β_NNP 1_CD virus_NN in_IN one_CD
          knee_NN and_CC the_DT same_JJ amount_NN of_IN the_DT adenoviral_NN vector_NN
          expressing_VBG luciferase_NN (_( Ad_NN ._. Luc_NNP )_) virus_NN in_IN the_DT opposite_JJ knee_NN
          as_IN the_DT control_NN ._.
          To_TO lavage_NN the_DT rabbit_NN knee_NN joints_NNS ,_, 1_CD ml_NN Gey_NNP 's_POS saline_NN
          was_VBD injected_VBN into_IN the_DT joint_JJ space_NN through_IN the_DT patellar_NN
          tendon_NN ._. After_IN manipulation_NN of_IN the_DT joint_NN ,_, the_DT needle_NN was_VBD
          reinserted_JJ and_CC the_DT fluid_NN was_VBD aspirated_JJ ._. Leukocytes_NNP in_IN
          recovered_VBD lavage_NN fluids_NNS were_VBD counted_VBN using_VBG a_DT
          hemocytometer_NN ._. The_DT levels_NNS of_IN TGF-β_NNP 1_CD in_IN conditioned_VBN media_NNS ,_,
          lavage_NN fluids_NNS and_CC sera_NN were_VBD measured_VBN using_VBG an_DT ELISA_NNP kit_NN
          (_( R_NN &_CC D_NNP Systems_NNPS ,_, Minneapolis_NNP ,_, MN_NNP ,_, USA_NNP )_) as_IN directed_VBN by_IN
          the_DT supplier_NN ._. The_DT levels_NNS of_IN sulfated_JJ GAGs_NNP in_IN lavage_NN
          fluids_NNS were_VBD determined_VBN using_VBG a_DT colorimetric_JJ dye-binding_JJ
          assay_NN using_VBG 1_CD ,_, 9_CD -_: dimethylmethylene_NN blue_JJ [_NN 23_CD ]_NN ._. The_DT
          levels_NNS of_IN total_JJ nitrite_NN in_IN lavage_NN fluids_NNS were_VBD measured_VBN
          with_IN Nitric_NNP Oxide_NNP Assay_NNP kits_NNS (_( Calbiochem_NNP ®_NN ;_: Biosciences_NNP
          Inc_NNP ,_, La_NNP Jolla_NNP ,_, CA_NNP ,_, USA_NNP )_) ._.
          Articular_NNP cartilage_NN fragments_NNS shaved_VBD from_IN the_DT femoral_NN
          condyles_NNS were_VBD placed_VBN into_IN 1_CD ml_NN Neuman-_NNP Tyell_NNP serum-free_JJ
          medium_NN (_( Gibco_NNP ,_, New_NNP York_NNP ,_, USA_NNP )_) to_TO measure_VB the_DT rate_NN of_IN
          proteoglycan_NN synthesis_NN ._. The_DT fragments_NNS were_VBD then_RB incubated_JJ
          with_IN 35_CD SO_NNP 
          4_CD 2_CD -_: (_( 20_CD μCi_NN )_) for_IN 24_CD hours_NNS at_IN 37_CD °_NN C_NNP ,_, and_CC
          the_DT media_NNS harvested_VBN and_CC stored_VBN at_IN -_: 20_CD °_NN C_NNP ._. Proteoglycans_NNP
          were_VBD extracted_VBN from_IN the_DT cartilage_NN by_IN incubation_NN for_IN 48_CD
          hours_NNS in_IN 1_CD ml_NN of_IN 0_CD ._. 5_CD M_NNP NaOH_NNP at_IN 4_CD °_NN C_NNP with_IN gentle_JJ agitation_NN ._.
          Following_VBG chromatographic_JJ separation_NN of_IN unincorporated_JJ
          35_CD SO_NNP 
          4_CD 2_CD -_: using_VBG PD-_NNP 10_CD columns_NNS (_( Pharmacia_NNP ,_,
          Uppsala_NNP ,_, Sweden_NNP )_) ,_, the_DT levels_NNS of_IN radiolabeled_JJ GAGs_NNP
          released_VBD onto_IN the_DT culture_NN media_NNS or_CC recovered_VBN by_IN alkaline_NN
          extraction_NN were_VBD quantitated_JJ by_IN scintillation_NN counting_VBG [_NN
          24_CD ]_NN ._.
        
        
          Histology_NNP
          For_IN histological_JJ analyses_NNS ,_, tissues_NNS harvested_VBN from_IN
          dissected_VBN knees_NNS were_VBD first_RB fixed_VBN in_IN 10_CD %_NN formalin_NN ._. The_DT
          fixed_VBN tissues_NNS were_VBD imbedded_JJ in_IN paraffin_NN ,_, sectioned_JJ at_IN 5_CD
          μm_NN ,_, and_CC stained_JJ with_IN H_NNP &_CC E_NNP ._.
        
        
          Statistical_NNP analysis_NN
          All_DT data_NNS collected_VBN are_VBP expressed_VBN as_IN mean_NN ±_NN standard_JJ
          error_NN ._. Statistical_NNP significance_NN was_VBD analyzed_VBN by_IN analysis_NN
          of_IN variance_NN and_CC Student_NNP 's_POS 
          t_NN test_NN ._. Correlation_NNP coefficients_NNS (_( 
          r_LS )_) were_VBD calculated_VBN using_VBG Pearson_NNP 's_POS
          method_NN ._.
        
      
      
        Results_NNS
        
          Expression_NNP of_IN TGF-β_NNP 1_CD after_IN intra-articular_JJ
          injection_NN of_IN Ad_NN ._. TGF-β_NNP 1_CD
          To_TO test_VB the_DT effects_NNS of_IN adenoviral-mediated_JJ human_JJ
          TGF-β_NNP 1_CD gene_NN expression_NN in_IN naïve_NN and_CC AIA_NNP rabbit_NN joints_NNS ,_, 1_CD
          ×_NN 10_CD 7_CD ,_, 1_CD ×_NN 10_CD 8_CD and_CC 1_CD ×_NN 10_CD 9_CD particles_NNS of_IN Ad_NN ._. TGF-β_NNP 1_CD were_VBD
          injected_VBN into_IN either_DT naïve_NN or_CC arthritic_JJ rabbit_NN knees_NNS ._. The_DT
          same_JJ amounts_NNS of_IN Ad_NN ._. Luc_NNP were_VBD injected_VBN into_IN the_DT
          contralateral_NN knees_NNS ._. Lavages_NNP were_VBD performed_VBN on_IN day_NN 3_CD ,_, day_NN
          7_CD and_CC day_NN 17_CD ,_, and_CC the_DT levels_NNS of_IN TGF-β_NNP 1_CD were_VBD determined_VBN by_IN
          ELISA_NNP (_( Fig_NNP ._. 1_LS )_) ._.
          TGF-β_NNP 1_CD expression_NN was_VBD detected_VBN in_IN all_DT knee_NN joints_NNS
          receiving_VBG either_CC 1_CD ×_NN 10_CD 8_CD or_CC 1_CD ×_NN 10_CD 9_CD viral_JJ particles_NNS ,_, with_IN
          higher_JJR levels_NNS detected_VBD in_IN the_DT arthritic_JJ knees_NNS ._. A_DT
          significant_JJ drop_NN in_IN TGF-β_NNP 1_CD expression_NN was_VBD observed_VBN after_IN
          17_CD days_NNS of_IN post-viral_JJ injection_NN ._. No_DT significant_JJ levels_NNS of_IN
          TGF-β_NNP 1_CD were_VBD detected_VBN in_IN the_DT 1_CD ×_NN 10_CD 7_CD viral_JJ particle_NN
          injection_NN group_NN and_CC in_IN the_DT contralateral_NN joints_NNS receiving_VBG
          the_DT different_JJ doses_NNS of_IN luciferase_NN virus_NN ._. Furthermore_RB ,_, no_DT
          significant_JJ expression_NN of_IN TGF-β_NNP was_VBD detected_VBN in_IN the_DT
          serum_NN ._.
          It_PRP is_VBZ important_JJ to_TO note_VB that_DT detection_NN of_IN TGF-β_NNP 1_CD in_IN
          the_DT synovial_NN fluid_JJ required_VBN acid_NN activation_NN ,_, suggesting_VBG
          that_IN the_DT protein_NN is_VBZ in_IN its_PRP$ latent_NN form_NN ._. Moreover_RB ,_, there_EX
          were_VBD no_DT observed_VBD therapeutic_JJ or_CC adverse_JJ effects_NNS following_VBG
          intra-articular_JJ injection_NN of_IN the_DT low_JJ dose_NN (_( 1_CD ×_NN 10_CD
          7_CD particles_NNS )_) of_IN Ad_NN ._. TGF-β_NNP 1_CD ._.
        
        
          Alterations_NNP in_IN joint_JJ anatomy_NN after_IN intra-articular_JJ
          Ad_NN ._. TGF-β_NNP 1_CD injection_NN
          Three_CD days_NNS after_IN injection_NN of_IN Ad_NN ._. TGF-β_NNP 1_CD ,_, the_DT knees_NNS
          receiving_VBG the_DT highest_JJS dose_NN of_IN virus_NN became_VBD enlarged_VBN with_IN
          a_DT reduction_NN in_IN joint_JJ movement_NN ._. In_IN addition_NN ,_, the_DT muscles_NNS
          adjacent_JJ to_TO the_DT joints_NNS showed_VBD signs_NNS of_IN swelling_VBG and_CC
          reduced_VBN movement_NN ._. The_DT animals_NNS were_VBD sacrificed_JJ on_IN day_NN 7_CD
          post-injection_JJ ,_, and_CC the_DT joints_NNS were_VBD analyzed_VBN ._. The_DT size_NN of_IN
          the_DT joints_NNS and_CC the_DT adjacent_JJ muscles_NNS increased_VBN
          dramatically_RB both_DT in_IN naïve_NN rabbits_NNS (_( 1_CD ._. 5_LS ×_NN contralateral_NN
          knees_NNS ,_, 
          P_NN <_NN 0_CD ._. 05_CD )_) and_CC in_IN AIA_NNP rabbits_NNS
          (_( 1_CD ._. 25_CD ×_NN contralateral_NN knees_NNS ,_, 
          P_NN <_NN 0_CD ._. 01_CD )_) (_( Fig_NNP ._. 2_LS )_) ._.
          The_DT movement_NN of_IN joints_NNS was_VBD also_RB severely_RB limited_VBN ,_, with_IN
          the_DT Ad_NN ._. Luc_NNP contralateral_NN knees_NNS moving_VBG freely_RB at_IN 180_CD °_NN
          whereas_IN the_DT knees_NNS treated_VBN with_IN Ad_NN ._. TGF-β_NNP 1_CD virus_NN could_MD only_RB
          move_VB at_IN 90_CD -_: 120_CD °_NN ._. The_DT limitation_NN to_TO joint_JJ movement_NN was_VBD not_RB
          due_JJ to_TO the_DT enlarged_JJ muscles_NNS since_IN ,_, when_WRB the_DT muscles_NNS were_VBD
          cut_VBN away_RB ,_, the_DT limitation_NN of_IN movement_NN was_VBD still_RB observed_VBN ._.
          In_IN addition_NN ,_, when_WRB the_DT joints_NNS were_VBD analyzed_VBN 17_CD days_NNS after_IN
          viral_JJ injection_NN ,_, at_IN a_DT time_NN when_WRB the_DT muscle_NN size_NN returned_VBD
          to_TO normal_JJ ,_, the_DT joint_NN still_RB could_MD not_RB move_VB freely_RB ._. The_DT
          limitation_NN to_TO joint_JJ movement_NN could_MD thus_RB be_VB due_JJ to_TO
          possible_JJ synovial_NN hyperplasia_NN or_CC effects_NNS on_IN ligaments_NNS or_CC
          cartilage_NN metabolism_NN ._.
          It_PRP is_VBZ important_JJ to_TO note_VB that_IN we_PRP did_VBD observe_VB an_DT
          increase_NN in_IN creatine_NN kinase_NN levels_NNS in_IN the_DT serum_NN that_WDT
          would_MD suggest_VB muscle_NN damage_NN (_( data_NNS not_RB shown_VBN )_) ._. In_IN contrast_NN
          to_TO the_DT high-dose_JJ TGF-β_NNP 1_CD group_NN ,_, only_RB a_DT very_RB mild_JJ effect_NN
          was_VBD observed_VBN on_IN the_DT gross_JJ joint_JJ structure_NN in_IN the_DT group_NN
          receiving_VBG 1_CD ×_NN 10_CD 8_CD viruses_NNS and_CC no_DT changes_NNS were_VBD observed_VBN in_IN
          the_DT group_NN receiving_VBG 1_CD ×_NN 10_CD 7_CD viruses_NNS ._.
        
        
          Effect_NN of_IN TGF-β_NNP 1_CD on_IN cartilage_NN metabolism_NN
          To_TO determine_VB whether_IN overexpression_NN of_IN TGF-β_NNP 1_CD had_VBD
          effects_NNS on_IN cartilage_NN metabolism_NN in_IN naïve_NN and_CC AIA_NNP rabbit_NN
          joints_NNS ,_, GAG_NNP synthesis_NN by_IN articular_NN cartilage_NN and_CC GAGs_NNP
          released_VBD into_IN synovial_NN fluid_JJ as_IN a_DT result_NN of_IN proteoglycan_NN
          breakdown_NN were_VBD measured_VBN ._. The_DT rabbit_NN joints_NNS receiving_VBG
          Ad_NN ._. TGF-β_NNP 1_CD had_VBD significant_JJ higher_JJR levels_NNS of_IN GAG_NNP release_NN ,_,
          compared_VBN with_IN the_DT contralateral_NN Ad_NN ._. Luc_NNP joints_NNS ,_, in_IN lavage_NN
          fluids_NNS at_IN day_NN 3_CD ,_, day_NN 7_CD and_CC day_NN 17_CD for_IN the_DT naïve_NN rabbits_NNS
          and_CC at_IN day_NN 7_CD for_IN the_DT AIA_NNP rabbits_NNS (_( Fig_NNP ._. 3_LS A_DT ,_, 3_CD B_NNP ,_, 3_CD C_NNP )_) ._. GAG_NNP
          release_NN levels_NNS correlated_JJ linearly_RB with_IN the_DT levels_NNS of_IN
          TGF-β_NNP 1_CD in_IN lavage_NN fluids_NNS (_( 
          r_LS =_SYM 0_CD ._. 937_CD )_) in_IN the_DT naïve_NN rabbits_NNS ._. In_IN
          addition_NN ,_, only_RB the_DT highest_JJS dose_NN of_IN Ad_NN ._. TGF-β_NNP 1_CD was_VBD able_JJ to_TO
          stimulate_VB GAG_NNP synthesis_NN in_IN the_DT naïve_NN rabbit_NN joints_NNS from_IN
          day_NN 7_CD and_CC day_NN 17_CD ,_, but_CC the_DT stimulation_NN was_VBD marginal_JJ ._. There_EX
          was_VBD no_DT statistically_RB significant_JJ difference_NN between_IN GAG_NNP
          synthesis_NN by_IN the_DT naïve_NN rabbits_NNS with_IN the_DT two_CD lower_JJR doses_NNS
          of_IN viral_JJ injections_NNS and_CC in_IN the_DT AIA_NNP rabbits_NNS (_( Fig_NNP ._.
          3_LS D_NNP ,_, 3_CD E_NNP ,_, 3_CD F_NN )_) ._.
          Taken_VBN together_RB ,_, these_DT results_NNS suggest_VBP that_IN
          intra-articular_JJ expression_NN of_IN TGF-β_NNP 1_CD stimulated_VBN cartilage_NN
          matrix_NN degradation_NN while_IN having_VBG only_RB a_DT minor_JJ effect_NN on_IN
          the_DT promotion_NN of_IN new_JJ matrix_NN synthesis_NN ._. This_DT is_VBZ in_IN
          contrast_NN to_TO the_DT results_NNS observed_VBD on_IN matrix_NN synthesis_NN in_IN
          chondrocytes_NNS in_IN culture_NN ,_, where_WRB TGF-β_NNP 1_CD was_VBD able_JJ to_TO
          stimulate_VB significant_JJ new_JJ matrix_NN synthesis_NN as_RB well_RB as_IN
          overcome_VB the_DT suppressive_JJ effects_NNS of_IN IL-_NNP 1_CD β_NN on_IN matrix_NN
          metabolism_NN [_NN 21_CD 25_CD ]_NN ._.
        
        
          Inhibition_NNP of_IN white_JJ blood_NN cell_NN infiltration_NN and_CC
          elevation_NN of_IN nitric_JJ oxide_NN synthesis_NN
          To_TO determine_VB whether_IN TGF-β_NNP 1_CD expression_NN could_MD inhibit_VB
          the_DT mild_JJ inflammation_NN induced_VBN by_IN intra-articular_JJ
          injection_NN of_IN high_JJ doses_NNS of_IN adenovirus_JJ or_CC the_DT severe_JJ
          inflammation_NN occurring_VBG in_IN the_DT AIA_NNP model_NN ,_, the_DT levels_NNS of_IN
          white_JJ blood_NN leukocytic_JJ infiltrate_VB in_IN the_DT synovial_NN lavage_NN
          fluids_NNS were_VBD determined_VBN (_( Fig_NNP ._. 4_LS )_) ._.
          The_DT joints_NNS of_IN naïve_NN rabbits_NNS receiving_VBG the_DT highest_JJS dose_NN
          of_IN Ad_NN ._. TGF-β_NNP 1_CD adenovirus_JJ had_VBD significantly_RB lower_JJR levels_NNS of_IN
          white_JJ blood_NN cell_NN infiltration_NN in_IN lavage_NN fluids_NNS at_IN day_NN 3_CD ,_,
          day_NN 7_CD and_CC day_NN 17_CD ._. The_DT white_JJ blood_NN cell_NN infiltration_NN in_IN
          the_DT naïve_NN joints_NNS directly_RB correlated_JJ with_IN TGF-β_NNP 1_CD
          expression_NN levels_NNS in_IN the_DT lavage_NN fluids_NNS (_( 
          r_LS =_SYM 0_CD ._. 954_CD )_) ._. In_IN the_DT AIA_NNP rabbit_NN knee_NN
          joints_NNS ,_, there_EX was_VBD a_DT reduction_NN in_IN the_DT infiltration_NN at_IN day_NN
          3_CD and_CC day_NN 7_CD compared_VBN with_IN the_DT contralateral_NN control_NN
          Ad_NN ._. Luc_NNP joints_NNS ,_, consistent_JJ with_IN TGF-β_NNP 1_CD having_VBG an_DT
          anti-inflammatory_JJ effect_NN ._. Surprisingly_RB ,_, TGF-β_NNP 1_CD expression_NN
          elevated_VBD nitrate_NN levels_NNS in_IN the_DT joints_NNS receiving_VBG high-dose_JJ
          injections_NNS of_IN TGF-β_NNP 1_CD adenovirus_JJ at_IN day_NN 3_CD ,_, day_NN 7_CD and_CC day_NN
          17_CD for_IN naïve_NN rabbits_NNS and_CC at_IN day_NN 7_CD for_IN the_DT AIA_NNP rabbits_NNS ,_,
          compared_VBN with_IN the_DT control_NN joints_NNS (_( Fig_NNP ._. 4_LS D_NNP ,_, 4_CD E_NNP ,_, 4_CD F_NN )_) ._. The_DT
          nitrate_NN levels_NNS also_RB directly_RB correlated_JJ with_IN the_DT levels_NNS
          of_IN TGF-β_NNP 1_CD in_IN lavage_NN fluids_NNS (_( 
          r_LS =_SYM 0_CD ._. 945_CD )_) for_IN naïve_NN rabbits_NNS ._.
          These_DT results_NNS suggested_VBD that_IN TGF-β_NNP 1_CD is_VBZ indeed_RB
          anti-inflammatory_JJ in_IN arthritic_JJ knees_NNS ,_, but_CC is_VBZ able_JJ to_TO
          induce_VB production_NN of_IN nitric_JJ oxide_NN through_IN an_DT unknown_JJ
          mechanism_NN ._.
        
        
          Histological_NNP analysis_NN of_IN the_DT intra-articular_JJ
          effects_NNS of_IN TGF-β_NNP 1_CD
          The_DT naïve_NN and_CC AIA_NNP rabbit_NN knee_NN joints_NNS receiving_VBG
          Ad_NN ._. TGF-β_NNP 1_CD and_CC Ad_NN ._. Luc_NNP were_VBD also_RB examined_VBN by_IN histology_NN ._.
          There_EX was_VBD significant_JJ fibroblast_NN proliferation_NN around_IN the_DT
          myofibers_NNS in_IN the_DT naïve_NN rabbits_NNS joint_JJ receiving_NN Ad_NN ._. TGF-β_NNP 1_CD ._.
          There_EX was_VBD also_RB mild_JJ hyperplasia_NN of_IN the_DT synovial_NN lining_NN ,_,
          but_CC without_IN any_DT evidence_NN of_IN inflammatory_JJ cells_NNS being_VBG
          observed_VBN (_( Fig_NNP ._. 5_LS A_DT ,_, 5_CD B_NNP )_) ._. There_EX were_VBD some_DT inflammatory_JJ cells_NNS
          in_IN the_DT contralateral_NN synovial_NN lining_NN ,_, but_CC no_DT evidence_NN of_IN
          synovitis_NNS (_( Fig_NNP ._. 5_LS C_NNP ,_, 5_CD D_NNP )_) ._. The_DT synovium_NN from_IN the_DT TGF-β_NNP 1_CD
          virus_NN treated_VBD joints_NNS was_VBD highly_RB fibrotic_JJ 17_CD days_NNS after_IN
          viral_JJ injection_NN ,_, with_IN evidence_NN of_IN osteometroplasia_NN found_VBD
          in_IN the_DT synovium_NN (_( Fig_NNP ._. 5_LS E_NNP ,_, 5_CD F_NN )_) but_CC with_IN no_DT evidence_NN of_IN
          inflammation_NN or_CC angiogenesis_NNS (_( Fig_NNP ._. 5_LS F_NN )_) ._.
          There_EX was_VBD mild_JJ inflammation_NN under_IN the_DT synovium_NN in_IN the_DT
          contralateral_NN joints_NNS receiving_VBG Ad_NN ._. Luc_NNP (_( Fig_NNP ._. 5_LS G_NNP ,_, 5_CD H_NNP )_) ._. The_DT
          synovium_NN in_IN the_DT Ad_NN ._. TGF-β_NNP 1_CD -_: treated_VBN AIA_NNP rabbits_NNS showed_VBD
          evidence_NN of_IN hyperproliferation_NN with_IN mild_JJ inflammation_NN
          (_( Fig_NNP ._. 5_LS I_PRP ,_, 5_CD J_NNP )_) ,_, compared_VBN with_IN the_DT contralateral_NN control_NN
          joints_NNS that_WDT had_VBD severe_JJ inflammation_NN (_( Fig_NNP ._. 5_LS K_NNP ,_, 5_CD L_NNP )_) ._. In_IN the_DT
          muscle_NN tissue_NN adjacent_JJ to_TO Ad_NN ._. TGF-β_NNP 1_CD -_: treated_VBN joints_NNS ,_, there_EX
          was_VBD evidence_NN of_IN both_DT fibroblast_NN and_CC myofibroblast_NN
          proliferation_NN between_IN myofibers_NNS with_IN intracellular_NN edema_NN ,_,
          but_CC there_EX was_VBD no_DT evidence_NN of_IN inflammation_NN or_CC myonecrosis_NNS
          (_( Fig_NNP ._. 5_LS M_NNP ,_, 5_CD N_NNP )_) ._. In_IN contrast_NN ,_, the_DT muscle_NN tissue_NN from_IN the_DT
          contralateral_NN controls_VBZ knees_NNS was_VBD normal_JJ (_( Fig_NNP ._. 5_LS O_NNP ,_, 5_CD P_NN )_) ._.
          There_EX was_VBD also_RB mild_JJ fibroblast_NN proliferation_NN and_CC synovial_NN
          inflammation_NN in_IN the_DT 1_CD ×_NN 10_CD 8_CD Ad_NN ._. TGF-β_NNP group_NN ,_, but_CC no_DT
          significant_JJ histological_JJ changes_NNS were_VBD observed_VBN in_IN the_DT 1_CD ×_NN
          10_CD 7_CD viral_JJ group_NN ._.
          These_DT data_NNS taken_VBN together_RB suggest_VBP that_IN TGF-β_NNP 1_CD is_VBZ able_JJ
          to_TO stimulate_VB fibrogenesis_NNS and_CC to_TO suppress_VB inflammation_NN ._.
          Moreover_RB ,_, the_DT results_NNS suggest_VBP that_WDT elevated_VBD TGF-β_NNP 1_CD levels_NNS
          result_VBP in_IN chondrogenesis_NNS within_IN the_DT synovial_NN tissue_NN ._.
        
      
      
        Discussion_NNP
        TGF-β_NNP 1_CD is_VBZ a_DT mutifunctional_NN cytokine_NN that_WDT plays_VBZ an_DT
        important_JJ role_NN in_IN immunomodulation_NN ,_, inflammation_NN and_CC tissue_NN
        repair_NN ._. Given_VBN that_IN TGF-β_NNP 1_CD is_VBZ able_JJ to_TO induce_VB new_JJ matrix_NN
        synthesis_NN from_IN chondrocytes_NNS in_IN culture_NN as_RB well_RB as_IN able_JJ to_TO
        block_VB inflammation_NN 
        in_IN vivo_NN ,_, it_PRP has_VBZ been_VBN proposed_VBN that_IN
        local_JJ intra-articular_JJ gene_NN transfer_NN of_IN TGF-β_NNP 1_CD could_MD be_VB
        therapeutic_JJ for_IN the_DT treatment_NN of_IN rheumatoid_NN arthritis_NN as_RB
        well_RB as_IN osteoarthritis_NNS ._. To_TO examine_VB the_DT effects_NNS of_IN TGF-β_NNP 1_CD on_IN
        joint_JJ pathology_NN ,_, we_PRP used_VBD adenovirus-mediated_JJ
        intra-articular_JJ gene_NN delivery_NN to_TO confer_VB sustained_VBN
        intra-articular_JJ TGF-β_NNP 1_CD expression_NN in_IN both_DT naïve_NN and_CC
        arthritic_JJ rabbit_NN knee_NN joints_NNS ._. Intra-articular_NNP injection_NN of_IN
        Ad_NN ._. TGF-β_NNP 1_CD virus_NN into_IN the_DT rabbit_NN knee_NN resulted_VBD in_IN
        dose-dependent_JJ elevated_VBD levels_NNS of_IN expression_NN of_IN TGF-β_NNP 1_CD in_IN
        the_DT synovial_NN fluid_JJ ,_, but_CC not_RB in_IN the_DT serum_NN ._.
        Intra-articular_NNP TGF-β_NNP 1_CD expression_NN resulted_VBD in_IN
        dose-dependent_JJ biological_JJ effects_NNS in_IN the_DT rabbit_NN knee_NN as_RB
        well_RB as_IN in_IN adjacent_JJ muscle_NN ._. In_IN particular_JJ ,_, local_JJ
        intra-articular_JJ expression_NN in_IN naïve_NN joints_NNS stimulated_VBN
        cartilage_NN breakdown_NN ,_, as_IN measured_VBN by_IN synovial_NN GAG_NNP levels_NNS ,_,
        without_IN enhancing_VBG new_JJ matrix_NN synthesis_NN ._. In_IN addition_NN ,_, TGF-β_NNP 1_CD
        expression_NN stimulated_VBN nitric_JJ oxide_NN production_NN ._. Similarly_RB ,_,
        in_IN arthritic_JJ joints_NNS where_WRB TGF-β_NNP 1_CD expression_NN inhibited_VBD white_JJ
        blood_NN cell_NN infiltration_NN ,_, it_PRP also_RB stimulated_VBN GAG_NNP release_NN and_CC
        nitric_JJ oxide_NN production_NN ._. Although_IN there_EX was_VBD a_DT reduction_NN in_IN
        inflammation_NN in_IN arthritic_JJ joints_NNS ,_, TGF-β_NNP 1_CD expression_NN induced_VBD
        fibrogenesis_NNS and_CC muscle_NN edema_NN ._. In_IN addition_NN ,_, TGF-β_NNP 1_CD
        expression_NN in_IN the_DT adenovirally_RB infected_JJ synovial_NN lining_NN
        also_RB resulted_VBD in_IN induction_NN of_IN chondrogenesis_NNS in_IN the_DT
        synovium_NN ._. Elevated_NNP TGF-β_NNP 1_CD expression_NN in_IN the_DT synovial_NN fluid_JJ
        thus_RB resulted_VBD in_IN a_DT variety_NN of_IN adverse_JJ pathological_JJ
        changes_NNS ._.
        A_DT previous_JJ study_NN examined_VBD the_DT effect_NN of_IN Ad_NN ._. TGF-β_NNP 1_CD in_IN the_DT
        knee_NN joints_NNS of_IN naïve_NN C_NNP 57_CD /_NN Bl_NNP /_NN 6_CD mice_NNS where_WRB gene_NN transfer_NN of_IN
        TGF-β_NNP 1_CD to_TO the_DT mouse_NN knee_NN resulted_VBD in_IN hyperplasia_NN of_IN the_DT
        synovium_NN as_RB well_RB as_IN in_IN chondro-osteophyte_JJ formation_NN at_IN the_DT
        chondrosynovial_NN junctions_NNS [_NN 10_CD ]_NN ._. The_DT present_JJ experiments_NNS
        have_VBP shown_VBN similar_JJ effects_NNS on_IN synovial_NN proliferation_NN ,_, but_CC
        also_RB have_VBP extended_VBN the_DT murine_NN studies_NNS to_TO examine_VB the_DT
        effects_NNS of_IN TGF-β_NNP 1_CD in_IN both_DT diseased_JJ knee_NN joints_NNS and_CC normal_JJ
        knee_NN joints_NNS in_IN the_DT rabbit_NN ._. Similar_JJ to_TO the_DT previous_JJ report_NN ,_,
        we_PRP have_VBP observed_VBN evidence_NN for_IN intra-synovial_JJ chondrogenesis_NNS
        as_RB well_RB as_IN osteometroplasia_NN following_VBG TGF-β_NNP 1_CD gene_NN transfer_NN ._.
        Whether_IN TGF-β_NNP 1_CD directly_RB or_CC indirectly_RB stimulates_NNS
        proliferation_NN of_IN synovium_NN is_VBZ unclear_JJ ,_, but_CC this_DT pathology_NN
        apparently_RB is_VBZ mediated_JJ through_IN an_DT IL-_NNP 1_CD β-independent_JJ
        mechanism_NN ._.
        It_PRP has_VBZ been_VBN speculated_VBN that_IN intra-articular_JJ delivery_NN of_IN
        TGF-β_NNP 1_CD would_MD result_VB in_IN enhanced_JJ synthesis_NN of_IN new_JJ matrix_NN [_NN 9_CD
        ]_NN ._. Indeed_RB ,_, we_PRP have_VBP reported_VBN previously_RB that_IN the_DT TGF-β_NNP 1_CD
        gene_NN is_VBZ more_RBR effective_JJ than_IN insulin-like_JJ growth_NN factor_NN type_NN
        1_CD and_CC bone_NN morphogenetic_JJ protein_NN type_NN 2_CD genes_NNS in_IN
        stimulating_VBG new_JJ matrix_NN synthesis_NN from_IN rabbit_NN chondrocytes_NNS
        in_IN culture_NN ._. We_PRP have_VBP also_RB demonstrated_VBN that_IN TGF-β_NNP 1_CD is_VBZ able_JJ
        to_TO partially_RB overcome_VB the_DT inhibition_NN of_IN new_JJ matrix_NN
        synthesis_NN by_IN IL-_NNP 1_CD β_NN in_IN cultured_JJ chondrocytes_NNS ._. The_DT results_NNS
        presented_VBN in_IN the_DT present_JJ article_NN ,_, however_RB ,_, suggest_VBP that_IN
        TGF-β_NNP 1_CD expression_NN is_VBZ unable_JJ to_TO enhance_VB new_JJ matrix_NN synthesis_NN
        
        in_IN vivo_NN in_IN either_DT naïve_NN joints_NNS or_CC ,_, in_IN
        particular_JJ ,_, in_IN diseased_JJ joints_NNS ._. Moreover_RB ,_, it_PRP appears_VBZ as_IN if_IN
        TGF-β_NNP 1_CD confers_VBZ adverse_JJ effects_NNS by_IN stimulating_VBG cartilage_NN
        degradation_NN through_IN an_DT unknown_JJ mechanism_NN ._. In_IN contrast_NN to_TO
        the_DT adverse_JJ effects_NNS of_IN intra-articular_JJ adenoviral_NN gene_NN
        transfer_NN of_IN TGF-β_NNP 1_CD ,_, we_PRP have_VBP shown_VBN that_DT gene_NN transfer_NN of_IN
        insulin-like_JJ growth_NN factor_NN type_NN 1_CD to_TO the_DT rabbit_NN knee_NN
        results_NNS in_IN an_DT increase_NN in_IN new_JJ matrix_NN synthesis_NN without_IN any_DT
        adverse_JJ effects_NNS [_NN 17_CD ]_NN ._.
        Taken_VBN together_RB ,_, these_DT results_NNS suggest_VBP that_IN increasing_VBG
        the_DT intra-articular_JJ levels_NNS of_IN TGF-β_NNP 1_CD has_VBZ no_DT therapeutic_JJ
        effect_NN on_IN cartilage_NN metabolism_NN ,_, resulting_VBG instead_RB in_IN higher_JJR
        rates_NNS in_IN cartilage_NN degradation_NN ._. Use_NN of_IN the_DT synovium_NN as_IN a_DT
        target_NN tissue_NN for_IN TGF-β_NNP 1_CD gene_NN transfer_NN ,_, resulting_VBG in_IN
        elevating_VBG the_DT intra-articular_JJ level_NN ,_, is_VBZ thus_RB not_RB
        appropriate_JJ for_IN the_DT enhancement_NN of_IN repair_NN of_IN cartilage_NN
        defects_NNS ._. Instead_RB ,_, for_IN TGF-β_NNP 1_CD gene_NN therapy_NN to_TO be_VB effective_JJ
        in_IN promoting_VBG repair_NN of_IN damaged_VBN cartilage_NN ,_, the_DT level_NN of_IN
        TGF-β_NNP 1_CD will_MD need_VB to_TO be_VB highly_RB regulated_VBN as_RB well_RB as_IN
        expression_NN localized_JJ ._. TGF-β_NNP 1_CD expression_NN would_MD need_VB to_TO be_VB
        targeted_VBN ,_, at_IN the_DT appropriate_JJ levels_NNS ,_, to_TO the_DT site_NN of_IN
        cartilage_NN damage_NN ,_, such_JJ as_IN through_IN gene_NN transfer_NN to_TO
        chondrocytes_NNS or_CC stem_VB cells_NNS involved_VBN in_IN repairing_VBG the_DT
        damaged_JJ tissues_NNS ._.
        TGF-β_NNP 1_CD has_VBZ been_VBN shown_VBN to_TO be_VB therapeutic_JJ in_IN several_JJ
        different_JJ animal_NN models_NNS when_WRB expressed_VBD systemically_RB from_IN
        muscle_NN tissue_NN [_NN 26_CD 27_CD ]_NN ._. This_DT suggests_VBZ that_WDT elevated_JJ serum_NN
        levels_NNS of_IN TGF-β_NNP 1_CD can_MD reduce_VB general_JJ inflammation_NN as_RB well_RB as_IN
        inhibit_VB IL-_NNP 1_CD β_NN and_CC tumor_NN necrosis_NNS factor_NN alpha_NN production_NN ,_,
        resulting_VBG in_IN a_DT systemic_JJ therapeutic_JJ effect_NN ._. In_IN addition_NN ,_,
        TGF-β_NNP 1_CD has_VBZ been_VBN shown_VBN to_TO be_VB therapeutic_JJ in_IN murine_NN models_NNS of_IN
        collagen-induced_JJ arthritis_NN following_VBG delivery_NN in_IN
        genetically_RB modified_VBN T_NN cells_NNS [_NN 28_CD ]_NN ._. This_DT observation_NN
        suggests_VBZ that_IN targeting_VBG TGF-β_NNP 1_CD to_TO certain_JJ sites_NNS of_IN
        inflammation_NN through_IN the_DT use_NN of_IN arthogenic_JJ T_NN cells_NNS also_RB can_MD
        be_VB therapeutic_JJ ._. However_RB ,_, our_PRP$ results_NNS suggest_VBP that_IN local_JJ
        expression_NN of_IN TGF-β_NNP 1_CD ,_, unlike_IN systemic_JJ expression_NN ,_, is_VBZ not_RB
        therapeutic_JJ due_NN to_TO adverse_JJ pathologies_NNS associated_VBN with_IN
        elevated_VBD intra-articular_JJ TGF-β_NNP 1_CD expression_NN ._.
        Although_IN our_PRP$ results_NNS do_VBP not_RB preclude_VB the_DT development_NN of_IN
        gene_NN therapy_NN approaches_NNS to_TO express_VB regulated_VBN TGF-β_NNP 1_CD
        systemically_RB to_TO downmodulate_NN the_DT immune_JJ response_NN ,_, the_DT
        results_NNS suggest_VBP that_IN any_DT clinical_JJ application_NN of_IN local_JJ
        TGF-β_NNP 1_CD gene_NN transfer_NN should_MD proceed_VB with_IN caution_NN ._. TGF-β_NNP 1_CD is_VBZ
        clearly_RB a_DT potent_JJ cytokine_NN ,_, able_JJ to_TO confer_VB multiple_JJ effects_NNS
        when_WRB expressed_VBD intra-articularly_JJ 
        in_IN vivo_NN ._.
      
      
        Conclusion_NNP
        Gene_NNP transfer_VB represents_VBZ a_DT novel_NN method_NN for_IN obtaining_VBG
        high_JJ intra-articular_JJ levels_NNS of_IN therapeutic_JJ agents_NNS for_IN the_DT
        treatment_NN of_IN arthritis_NN ._. TGF-β_NNP 1_CD is_VBZ able_JJ to_TO stimulate_VB new_JJ
        matrix_NN synthesis_NN by_IN chondrocytes_NNS in_IN culture_NN as_RB well_RB as_IN able_JJ
        to_TO reduce_VB inflammation_NN 
        in_IN vivo_NN ._. In_IN this_DT report_NN ,_, the_DT effects_NNS
        of_IN intra-articular_JJ expression_NN on_IN both_DT naïve_NN and_CC arthritic_JJ
        rabbit_NN knee_NN joint_JJ pathology_NN were_VBD examined_VBN by_IN
        adenoviral-mediated_JJ intra-articular_JJ gene_NN transfer_NN of_IN
        TGF-β_NNP 1_CD ._. The_DT results_NNS suggest_VBP that_WDT elevated_VBD TGF-β_NNP 1_CD expression_NN
        confers_VBZ adverse_JJ joint_JJ pathology_NN including_VBG an_DT increase_NN in_IN
        cartilage_NN matrix_NN degradation_NN without_IN stimulating_VBG new_JJ matrix_NN
        synthesis_NN ._. In_IN addition_NN ,_, TGF-β_NNP expression_NN induces_VBZ muscle_NN
        edema_NN and_CC fibrogenesis_NNS ._.
        Although_IN TGF-β_NNP 1_CD may_MD have_VB certain_JJ anti-inflammatory_JJ
        properties_NNS ,_, it_PRP is_VBZ unable_JJ to_TO stimulate_VB repair_NN of_IN damaged_VBN
        cartilage_NN ,_, and_CC even_RB stimulates_NNS cartilage_NN degradation_NN ._.
        Moreover_RB ,_, elevated_VBD TGF-β_NNP 1_CD expression_NN also_RB induced_VBD muscle_NN
        edema_NN and_CC fibrogenesis_NNS ._. Gene_NNP transfer_NN of_IN TGF-β_NNP 1_CD to_TO the_DT
        synovium_NN is_VBZ thus_RB not_RB suitable_JJ for_IN treating_VBG intra-articular_JJ
        pathologies_NNS ,_, such_JJ as_IN the_DT repair_NN of_IN damaged_VBN cartilage_NN ,_,
        associated_VBN with_IN rheumatoid_NN arthritis_NN and_CC
        osteoarthritis_NNS ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
      
        Abbreviations_NNP
        Ad_NN ._. Luc_NNP =_SYM adenoviral_NN vector_NN expressing_VBG luciferase_NN ;_: Ad_NN ._. TGF_NNP
        =_SYM adenoviral_NN vector_NN expressing_VBG human_JJ transforming_VBG growth_NN
        factor_NN ;_: AIA_NNP =_SYM antigen-induced_JJ arthritis_NN ;_: ELISA_NNP =_SYM
        enzyme-linked_JJ immunosorbent_NN assay_NN ;_: GAG_NNP =_SYM glycosaminoglycan_NN ;_:
        H_NNP &_CC E_NNP =_SYM hematoxylin_NN and_CC eosin_NN ;_: IL_NNP =_SYM interleukin_NN ;_: TGF_NNP =_SYM
        transforming_VBG growth_NN factor_NN ._.
      
    
  
